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PURPOSE. To develop a time course study of vascularization and glial response to perinatal
asphyxia in hypoxic-ischemic animals, and to evaluate hypothermia as possible protective
treatment.
METHODS. We used retinas of 7-, 15-, 21-, and 30-day-old male Sprague-Dawley rats that were
exposed to perinatal asphyxia at either 378C (PA) or 158C (HYP). Born to term animals were
used as controls (CTL). We evaluated the thickness of the most inner layers of the retina (IR),
including internal limiting membrane, the retinal nerve fiber layer, and the ganglion cell layer;
and studied glial development, neovascularization, adrenomedullin (AM), and VEGF by
immunohistochemistry, immunofluorescence, and Western blot.
RESULTS. A significant increment in IR thickness was observed in the PA group from postnatal
day (PND) 15 on. This alteration was concordant with an increased number of new vessels
and increased GFAP expression. The immunolocalization of GFAP in the internal limiting
membrane and perivascular glia of the IR and in the inner processes of Mu¨ller cells was
coexpressed with AM, which was also significantly increased from PND7 in PA animals. In
addition, VEGF expression was immunolocalized in cells of the ganglion cell layer of the IR
and this expression significantly increased in the PA group from PND15 on. The retinas of the
HYP group did not show differences when compared with CTL at any age.
CONCLUSIONS. This work demonstrates that aberrant angiogenesis and exacerbated gliosis seem
to be responsible for the increased thickness of the inner retina as a consequence of perinatal
asphyxia, and that hypothermia is able to prevent these alterations.
Keywords: retina, ischemic proliferative retinopathy, retinopathy of prematurity,
angiogenesis, gliosis, hypothermia, perinatal asphyxia
Perinatal asphyxia (PA) is the world’s most severe problem inperinatology services.1,2 It generates a global transient
hypoxia-ischemia status that damages the brain, spinal cord,
and retina.3–8 The degree and the length of PA are decisive for
the development of injury sequelae, such as attention-deficit
hyperactivity disorder,9 epilepsy, mental retardation, spasticity,
and visual or hearing alterations.10 A third of asphyctic
neonates develop serious long-term neurological injuries,
including several degrees of ischemic proliferative retinopathy
(IPR).11
We have described that adult animals (60 days old) that
have been exposed to PA develop retinal morphological
changes that are compatible with some alterations observed
in diseases, such as retinopathy in diabetes mellitus, retinal
vein occlusion, and retinopathy of prematurity (ROP), an
avoidable cause of visual impairment and blindness in
children.10–13 The changes observed in asphyctic animals
include ganglion cell degeneration, neovascularization of the
most inner layers of the retina (IR) (including the internal
limiting membrane, the retinal nerve fiber layer, and the
ganglion cell layer), and Mu¨ller cell hypertrophy in the inner
half layers of the retina (including the inner nuclear layer, the
inner plexiform layer [IPL], the internal limiting membrane, the
retinal nerve fiber layer, and the ganglion cell layer), with
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significant increased expression of glial fibrillary acidic protein
(GFAP) in activated Mu¨ller cells.7
Animal studies have shown that a reduction in core
temperature protects the nervous system against ischemic
damage by a reduction of the metabolism, decreasing reactive
oxygen species, and inhibiting the toxic release of nitric oxide
(NO).3,5,8,14,15 Hypothermia during PA prevents central ner-
vous system (CNS) damage when compared with animals kept
under normothermic conditions.3,5,8 According to our previ-
ous studies, when asphyxia occurs at low temperature (158C)
there are no deaths among neonates, whereas the same
procedure performed at 378C results in 60% pup mortality.5,16
The use of hypothermia has been proposed as a treatment to
reduce secondary neuronal injury after severe perinatal
hypoxia-ischemia in humans.15,17–19
Adrenomedullin (AM) is a peptide hormone initially isolated
from extracts of human pheochromocytoma.20 It is involved in
the induction of vasodilatation, regulation of cell proliferation,
and angiogenesis.21 The expression and secretion of this
peptide are induced by inflammatory cytokines and hypoxia
through activation of hypoxia inducible factor 1 (HIF-1). Under
low oxygen pressure conditions (<2%), transactivation of the
AM promoter with increased translation of AM peptide was
observed.22 In the CNS, AM is secreted by neurons and glia.23
AM is also expressed in RPE, in the aqueous humor, and in the
vitreous of human patients with proliferative vitreoretinop-
athy,24 diabetic retinopathy,25 and uveitis or vitreoretinal
disorders.26 A full description of the cellular populations that
express AM in the rat retina is not available, and its
pathophysiological role in hypoxia-ischemia is not yet well
understood.
Development of retina vascularization, under physiological
or pathophysiological conditions, is a complex process that
involves different factors, such as VEGF.27 Increased levels of
VEGF were identified in models of retinal ischemia.28 The key
factor regulating angiogenesis in response to hypoxia is likely
to be HIF-1, whose activation stimulates the production of
VEGF.27,29
Considering that PA induces the thickening of the IR and
the presence of newly formed vessels in adult hypoxic/
ischemic animals,7 the aim of the present work was to evaluate
the impact of hypoxia-ischemia in a time course study
analyzing the changes induced by PA in the retinal structure.
We specially focused on the development of retinal damage
elicited by vascularization and gliosis, the study of the
expression and distribution of pro-angiogenic factors, such as




Severe PA was induced using a noninvasive model of hypoxia-
ischemia, as described.6 Sprague-Dawley albino rats with
genetic quality and sanitary certification from the animal
facility of our institution were cared for in accordance with
the guidelines published in the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research, and in the
National Institutes of Health (NIH) Guide for the Care and
Use of Laboratory Animals (NIH Publication No. 85-23,
revised 1985, available from: Office of Science and Health
Reports, National Center for Research Resources, Bethesda,
MD), and the principles presented in the ‘‘Guidelines for the
Use of Animals in Neuroscience Research’’ by the Society for
Neuroscience (available from the Society for Neuroscience,
FIGURE 1. Perinatal asphyxia increases the thickness of the IR throughout time. Thickness was measured in hematoxylin-eosin–stained slides.
Significant increase of the thickness of the IR was observed in the PA group when the animals were 15 days of age and older. The thickness of the IR
was not modified in the HYP group with respect to the CTL group. Upper panel: time course graph of IR thickness for the four evaluated groups.
Each bar represents the mean 6 SD of six sections per animal in five animals per group. *P < 0.05 versus CTL at the same age. Lower panel:
representative hematoxylin-eosin images of 30-day-old CTL, PA, and HYP retinas. Caliber shows IR thickness. IR includes the internal limiting
membrane, the retinal nerve fiber layer, and the ganglion cell layer. INL, inner nuclear layer; EPL, external plexiform layer; ENL, external nuclear
layer. Scale bars: 20 lm.
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Washington, DC; published in the Membership Directory of
the Society, pp. xxvii–xxviii, 1992). The animal model
described below was approved by the Ethical Committee of
CICUAL (Comite´ Institucional para el Uso y Cuidado de
Animales de Laboratorio) (Resolution No. 2079/07), Facultad
de Medicina, Universidad de Buenos Aires, Argentina. Appro-
priate proceedings were performed to minimize the number
of animals used and their suffering, pain, and discomfort.
Animals were kept under standard laboratory conditions at
248C, with light/dark cycles of 12/12 hours, and food and
water were given ad libitum. Thirty-two timed-pregnant
Sprague-Dawley rats were killed by decapitation and immedi-
ately hysterectomized after their first pup was delivered
vaginally. These normally delivered, nonmanipulated pups
were used as controls (CTLs; n ¼ 5 per group). Full-term
fetuses, still inside the uterus, were subjected to asphyxia
performed by transient immersion of both uterine horns in a
water bath for 20 minutes at either 378C (PA; n¼ 5 per group)
or at 158C (HYP; n¼ 5 per group). For the hypothermia group,
the temperature of 158C was chosen because it allows the
highest pup survival rate.16,30 After asphyxia, the uterine
horns were opened, pups were removed, dried of delivery
fluids, stimulated to breathe, and their umbilical cords were
ligated. The pups were then placed for recovery under a
heating lamp and given to a surrogate mother. Time of
asphyxia was measured as the time elapsed from the
hysterectomy up to the recovery from the water bath. The
overall mortality rate was similar to that previously reported,6
FIGURE 2. Increase of GFAP expression induced by PA and reversion by HYP. Representative images of GFAP immunolocalization in the IR of CTL,
PA, and HYP animals that were 15 (top) and 30 days of age (bottom). Increased GFAP expression was observed in Mu¨ller cells of PA of both ages and
was significantly increased with respect to CTL. HYP retinas did not show differences when compared with the CTL retinas. PA-15PND animals
showed GFAP immunolocalization at perivascular glial cells (horizontal arrows) localized in the IR, whereas PA-30PND rats showed GFAP
immunoreactivity also at glial processes of the retinal IPL and INL (vertical arrows). IR includes the internal limiting membrane, the retinal nerve
fiber layer, and the ganglion cell layer. Scale bars: 10 lm.
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60% for the PA group and 0% for the HYP group. To avoid the
influence of hormonal variations due to the female estrous
cycle, only male rats were included in this study.
Tissue Processing and Measurement of Retinal
Thickness
CTL, PA, and HYP rats of 7, 15, 21, and 30 days of age
(postnatal day [PND]7, PND15, PND21, and PND30, respec-
tively) were intraperitoneally anesthetized with chloral hydrate
28% weight/volume (0.1 mL/100 g body weight) and
intracardially perfused with physiological solution followed
by 4% paraformaldehyde in 0.1 M, pH 7.4, phosphate buffer at
48C. After enucleating, anterior segments of the eyes, including
the lens, were discarded, and the posterior segments of the
eyes containing the retinas were post-fixed overnight in the
same fixative at 48C. Following cryoprotection with growing
series of sucrose (10%, 20%, and 30%) in PBS at 48C overnight,
tissues were included in Tissue-Tek OCT (Sakura, Alphen aan
den Rijn, The Netherlands), frozen in powdered dry ice, and
stored at 808C. Sections (15-lm thick) were obtained using a
Leitz ‘‘Lauda’’ cryostat (Leica Biosystems, Germany) and
mounted onto gelatin-coated slides (2.5% gelatin, 1% Elmer’s
glue [Elmer’s Products, Inc., Columbus, OH]), air dried at room
temperature, and stored at 808C until their use. For retinal
thickness measurements, hematoxylin-eosin staining was
performed and the thickness of the IR, which includes the
internal limiting membrane, the retinal nerve fiber layer, and
the ganglion cell layer, was measured.
Immunohistochemistry
For immunohistochemical assays, endogenous peroxidase
activity was blocked with 1% hydrogen peroxide in phosphate
buffer for 30 minutes. Then, sections were incubated with
blocking solution containing 10% normal goat serum in PBS,
pH 7.4, for 1 hour. Slides were incubated with a rabbit
polyclonal anti-AM antibody (at dilution 1:1000, according to
Garayoa et al.22), a mouse monoclonal anti-GFAP antibody
(dilution 1:500; Sigma-Aldrich, St. Louis, MO), or a rabbit
polyclonal anti-VEGF antibody (dilution 1:1000; Santa Cruz
Biotechnology, Santa Cruz, CA). Antibodies were incubated
overnight at 48C and their specificity corroborated in adjacent
sections by omission of primary antibodies. Immunoreactivity
was visualized with biotinylated goat antirabbit or antimouse
IgG (1:100; Sigma-Aldrich), developed with ABC kit (Vector
Laboratories, Burlingame, CA) and 0.03% 3,30diaminobenzidine
(Sigma-Aldrich), 3% nickel ammonium sulfate (Merck, Darm-
stadt, Germany), and 0.01% hydrogen peroxide diluted in 0.1 M
buffer acetate, yielding a black product. Sections were
dehydrated, cleared, and mounted. For colocalization studies,
the anti-AM rabbit polyclonal IgG at dilution 1:1000 and the
anti-GFAP monoclonal mouse IgG at dilution 1:500 were
employed. Following overnight incubation with both primary
antibodies, colocalization studies were performed by immuno-
fluorescence technique using Alexa fluor 555 coupled
antirabbit IgG (dilution 1:300; Life Technologies, Carlsbad,
CA) and FITC-coupled antimouse IgG (at dilution 1:300; Vector
Laboratories). Counterstaining of nuclei was made with 40-6-
diamidino-2-phenylindole (DAPI) (1:1000; Sigma-Aldrich) to
identify cellular localization.
Tomato Lectin Histochemistry
To study vessel distribution, some retina sections were
stained with biotinylated Lycopersicum esculentum (tomato)
lectin (Sigma-Aldrich) at a 1:150 dilution and revealed with an
ABC kit followed by diaminobenzidine-Nickel. After the
histochemical process, some slides were counterstained with
cresyl violet.
SDS-PAGE and Western Blotting
The retinas of CTL, PA, and HYP animals of 7, 15, 21, and 30
days of age (PND7, PND15, PND21, PND30, respectively) were
dissected, frozen, and stored at808C until used. Tissues were
homogenized (1:3, wt/vol) in HEPES buffer (20 mM N-[2-
hydroxethyl]piperazine-N 0-[2-ethanesulfonic acid], pH 7.2,
containing 0.2 M sucrose, 1 mM EDTA, 5 mM dithiothreitol,
FIGURE 3. Increase in astroglia markers was induced by PA and reversed by HYP. Western blot analysis of GFAP expression. PA group showed
increased GFAP expression levels with respect to CTL in all age groups studied. In contrast, GFAP expression in the HYP group did not show
significant differences when compared with CTL of the same age. Upper panel: representative images of Western blots assays. b-tubulin was used as
a loading control. Lower panel: quantification of GFAP levels. *P < 0.05 versus CTL at the same age.
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10 lg/mL soybean trypsin inhibitor, 10 lg/mL leupeptin, 2 lg/
mL pepstatin, and 0.1 mM phenylmethylsulfonyl fluoride). All
procedures were carried out at 48C. Homogenates were
centrifuged for 30 minutes at 15,000g and the supernatants
collected. In order to use similar amounts of proteins from
each sample (25 lg), protein concentration was determined by
the Bradford method, with bovine serum albumin as standard,
using a NanoDrop spectrophotometer (ND100; Thermo,
Wilmington, DE). Then, supernatant samples were mixed 1:1
with sample buffer (10 mL Tris-HCl 0.5 M, pH 6.8, 16 mL SDS
10% [wt/vol], 8 mL glycerol, 2 mL 2-mercaptoethanol, and 0.2
mL bromophenol blue 0.1% [wt/vol]) and heated for 3 minutes
at 958C. Samples were run on SDS–polyacrylamide gels (10%
running gel with 3.5% stacking gel), with 0.25 M Tris–glycine,
pH 8.3, as the electrolyte buffer, in a Bio-Rad Mini-Protein II
(Bio-Rad, Madrid, Spain). Kaleidoscope prestained standards
(Bio-Rad) were used as molecular weight markers. For Western
blot analysis, proteins were transferred at 1.5 mA/cm2 for 1
hour onto 0.2-lm polyvinylidene difluoride (PVDF) mem-
branes (Immobilon-P; Millipore, Bedford, MA) by semi-dry
transfer methods (Bio-Rad). For protein identification, mem-
branes were incubated overnight at 48C with the rabbit
polyclonal anti-AM IgG at dilution 1:1000 or with the mouse
monoclonal anti-GFAP antibody at dilution 1:1000. To stan-
dardize the results, monoclonal IgG anti-b-tubulin (Sigma-
Aldrich) was used at dilution 1:10,000 in the same membranes.
To visualize immunoreactivity, membranes were incubated
with antirabbit or antimouse peroxidase-labeled IgGs, devel-
oped with a chemoluminiscence kit (GE Biosciences, Miami,
FL), and exposed to x-ray blue films (CEA, Stra¨ngna¨s, Sweden).
Developed films were scanned with a computer-assisted
densitometer (GS-800; Bio-Rad) and optical density quantified
by NIH Scion Image software (developed by Wayne Rasband,
1995, NIH, Research Services Branch, NIMH, Bethesda, MD).
Image Analysis
Six retinal sections from five animals of each experimental
group were analyzed. Care was taken on selecting anatomically
matched areas of retina among animals before assays. Relative
optical density (ROD), immunoreactive cellular area, and
number of immunoreactive cells (or tomato lectin reactive
vessels) were analyzed using an Olympus BH2 microscope
(Olympus Optical Corporation, Tokyo, Japan) attached to a
video camera (CCD; Sony-XC77, San Diego, CA) and coupled to
a computer equipped with a video card (Data Translation,
Marlboro, MA). The central area of the sagittal plane was
FIGURE 4. Increased vascularization induced by PA and reversion by HYP. Images are representative of tomato lectin histochemistry in PND15 and
PND30 retinas. Vessels with both small and large diameter (arrows) were observed in the IR of the PA group at both PND15 and PND30. IR is the
layer conformed by the internal limiting membrane, the retinal nerve fiber layer, and the ganglion cell layer. Scale bar: 40 lm. The graphic shows
the significantly increased number of vessels observed in PND15 PA and PND30 PA groups when compared with CTL groups (*P < 0.05). PND7 did
not show significant changes in the number of vessels among groups. HYP treatment reverted blood vessel density to normal values.
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chosen for each retina. Thickness of the IR, including the
internal limiting membrane, the retinal nerve fiber layer, and
the ganglion cell layer, was measured. Mean thickness of a 160-
lm length of retina segment was measured, and 10 fields per
each retina were studied. Results show the thickness mean
value of 10 fields. Scion Image software (NIH) was used to
measure IR area thickness and to evaluate reactivity and
immunoreactivity. Only those cells that had a gray level darker
than a defined ‘‘threshold’’ criteria (defined as the optic density
3-fold higher than the mean background density) were
considered specific immunoreactively stained cells. The mean
background density was measured in a region devoid of
immunoreactivity, immediately adjacent to the analyzed region.
ROD was calculated using a gray scale of 255 gray levels. To
avoid external variations, all images were taken the same day
and under the same light. The number of cells was measured in
retina segments of exactly 160 lm in length. Four segments
were measured in each retinal section. Because immunohisto-
chemistry and Western blotting are semiquantitative tech-
niques, ROD values were expressed as percentage of change
with respect to the CTL group, considering CTL’s ROD as
100%. Colocalization was studied by immunofluorescence
using a Nikon C1 Plus laser microscope (Nikon Inverted
Research Microscope Eclipse Ti; Nikon Corp., Tokyo, Japan)
and images analyzed with the EZ-C1 software (EZ-C1 Software
v3.9; Nikon Corp.). Adobe Photoshop software (Adobe Photo-
shop CS5; Adobe Systems, Inc., Ottawa, ON, Canada) was used
for digital manipulation of only brightness and contrast when
preparing the shown images.
Statistical Analysis
Values are expressed as mean 6 SD. At least two similar
separate experiments were evaluated in all cases. Twelve
sections of each animal were analyzed. Results were evaluated
using one-way ANOVA and comparisons between groups were
made by Fisher, Scheffe, and Bonferroni-Dunn tests, using the
GraphPad software (GraphPad Software, San Diego, CA).
Differences were considered significant when P was less than
0.05.
RESULTS
The Thickness of the Most Inner Layers of the
Retina Increases Throughout Time by Perinatal
Asphyxia
Structural changes were evidenced in the IR of the PA group
when compared with the CTL group, considering IR as the
layer conformed by the internal limiting membrane, the retinal
nerve fiber layer, and the ganglion cell layer. A significant
increase in the thickness of the IR was observed in PA animals
with respect to CTL at 15 days of age, and this increment was
maintained in up to 30-day-old animals (Fig. 1). HYP prevented
retinal thickening and the values from these retinas were
undistinguishable from the control group (Fig. 1).
Increases in Astroglia and New Vessel
Development Are Responsible for Thickening of
the IR
Astroglial state of the retina was evaluated by GFAP immuno-
histochemistry and Western blotting in the retinas of rats from
7 to 30 days of age (Figs. 2, 3). A significant increase in GFAP
expression was observed in retinas of the PA group when
compared with those of CTL animals at all evaluated ages,
whereas no alterations were observed in HYP with respect to
CTL (Fig. 3). The maximum difference in GFAP expression was
observed at PA-PND15 both by immunohistochemistry (Fig. 2)
and by Western analysis (Fig. 3), where a 237% 6 10%
increment was seen for this time period (Fig. 3). GFAP
immunoreactivity was located in the internal limiting mem-
brane and in the perivascular glial cells of the IR in the PA-
PND15 group (Fig. 2). In older animals (PND30), GFAP
expression was also observed in the internal processes of
FIGURE 5. PA induces higher AM expression in Mu¨ller cells, and reversion by HYP. Representative images of AM immunolocalization (red color) in
the IR of CTL, PA, and HYP animals of 15 (top) and 30 days of age (middle). Increased AM expression was observed at PA of both ages with respect
to CTL. HYP did not show significant differences when compared with CTL. AM was localized in Mu¨ller cells of the IR, and along glial processes at
IPL and INL. Nuclei were localized by DAPI staining (blue). IR is the layer conformed by the internal limiting membrane, the retinal nerve fiber layer,
and the ganglion cell layer. Nuclei were counterstained with DAPI (blue). Scale bars: 15 lm. The graphic shows significantly increased ROD
observed in PND15 PA and PND30 PA groups when compared with CTL groups (*P < 0.05). No changes were observed in HYP.
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Mu¨ller cells, crossing the IPL (Fig. 2). Alterations in neither
localization nor protein expression levels were found in the
HYP group when compared with the CTL animals at any of the
evaluated ages (Figs. 2, 3).
The vascularization of the IR was studied by tomato lectin
histochemistry. Increased vascularization was observed in PA
with respect to CTL. A significant increment of 103% 6 11% (P
< 0.01) in the number of vessels in the retina of PA-PND15 was
observed compared with their normoxic counterparts (Fig. 4),
and this increase was maintained at PND30. No differences
were observed in the number of retinal vessels between CTL
and HYP at any evaluated age (Fig. 4).
Effect of PA on the Expression of Retinal
Angiogenic Factors
AM expression in the retina was evaluated by immunofluores-
cence and Western blotting. AM expression was detected in
the processes of Mu¨ller cells of the IPL and in the IR from 15-
day-old rats onwards (Fig. 5). After performing morphometric
studies of AM expression, a significant increase on ROD was
detected in the IR of PA-PND15 with respect to CTL-PND15
animals (90% 6 13%, P < 0.05). A similar pattern was observed
in the PND30 group (112% 6 6%, P < 0.05) (Fig. 5). HYP
animals showed no significant differences in comparison with
CTL for any studied age. Western blot of AM expression
showed that PND15 animals had a higher expression of this
peptide than younger rats (Fig. 6). CTL-PND15 animals showed
a significant 152% 6 13% increase (P < 0.05) when compared
with the CTL-PND7 group. All PA groups showed significant
AM expression increment in relation to CTL animals (PND7 ¼
143% 6 33%, PND15 ¼ 42% 6 3%, PND21 ¼ 51% 6 5%, and
PND30 ¼ 22% 6 11%, P < 0.05) (Fig. 6). Hypothermic
treatment showed to be effective for the prevention of
increased AM expression, resulting in no differences with
respect to CTL.
Confocal immunofluorescence was used to perform coloc-
alization studies between AM and GFAP. Colocalization of both
immunoreactivities was found in the processes of Mu¨ller cells
of the IPL and in the IR for rats that were 15 days old or older
(Fig. 7). The PA group showed a concomitant increase in AM
and GFAP immunofluorescent area, whereas similarities in the
immunofluorescent colocalizing area were observed between
CTL and HYP retinas (Fig. 7).
Expression and immunolocalization of VEGF were studied
in the retinas of PND15 and PND30 rats. VEGF distribution was
observed in the soma of cells in the ganglion cell layer of the
IR. Morphometric studies revealed that the PA-PND15 group
showed a significant 98% increase in the number of VEGF
immunoreactive neurons, a significant 61% increment in the
FIGURE 6. Increased AM expression was induced by PA and reverted by HYP. Western blot analysis of the expression of AM in the experimental
groups. The PA group showed increased AM expression levels with respect to the CTL group in all age groups. The HYP group did not show
significant differences in relation to the CTL group. Top: representative images of Western blot assays. b-tubulin was used as a loading control.
Bottom: quantification of AM levels. *P < 0.05 significant versus CTL at the same age.
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VEGF immunoreactive cell area, and a significant 7% increased
VEGF ROD with respect to CTL at PND15 (Fig. 8). PA-PND30
retinas showed similar VEGF alterations than PA-PND15 with
respect to CTL in the three parameters examined (Fig. 8). Both
evaluated ages showed no significantly different VEGF mor-
phometric values between HYP and CTL retinas (Fig. 8).
DISCUSSION
In the present study, we have shown that animals that had
suffered PA develop a significant increase in the thickness of
the IR, and that this occurs as a result of at least two factors:
exacerbation of astroglial response and formation of new blood
vessels. The finding that retinal changes occur at an early
postnatal time is very relevant, opening the possibility for a
therapeutic window.
The exposure to hyperoxia in neonatal intensive care
preterm infants produces a high susceptibility to develop
neurological and retinal injuries that include varying degrees of
IPR.7 Perinatal asphyxia in rats has proved to be a useful model
for studying retinopathy,7,8 as the induction of hypoxia-
ischemia in the perinatal period produces morphological,
biochemical, and molecular changes. The development of the
rat CNS at birth is equivalent to the one found in human fetuses
at 32 weeks of gestation.12 Therefore, the model of asphyxia
used in the present work offers the possibility of studying
changes that may occur in the premature human CNS,
including the retina.
In a previous work, we described, at structural and
ultrastructural levels, alterations produced by PA in the IR of
60-day-old animals. These included formation of new vessels,
and hypertrophy of Mu¨ller cells and perivascular astroglia.7 We
also observed increased enzymatic NO synthase (NOS) activity
and age-dependent expression of NOS in hypoxic retinas.8
Here we describe age-dependent alterations in the inner half
layers of the retina produced by PA because of an early
formation of vessels and an early expression of AM and GFAP in
the hypoxic retinas.
The most important functions of AM are the induction of
vasodilatation, regulation of cell proliferation, and angiogene-
sis.21 Recently, AM localization in Mu¨ller cells of mouse retina
and its signaling pathway has been described.31 The localiza-
tion of AM in the inner processes of Mu¨ller cells may be related
to the promotion of angiogenesis in the IR. Under hypoxic
conditions, AM may protect the retina through its vasodilatory
activity; however, when animals are subjected to PA, a severe
AM increase is detected. Significant alterations of AM
expression were observed in 7-day-old retinas of asphyctic
animals. Although this increase may activate angiogenesis
development, new vessel construction shall demand more time
being observed later, at 15 days of age. Our results suggest the
possible action of AM in retina promoting vascularization
development. To establish the exact developmental moment
when AM stimulates angiogenesis, future efforts will be
focused on the study of genomic responses of the hypoxic
retina.
These results suggest that AM may be a pharmacological
target to intervene in children in high risk of developing
retinopathy. Several inhibitors of AM function have been
described. These include a monoclonal antibody,32 the peptide
fragment AM 22-52,33 and a series of small molecules.34,35 All
these potential drugs need to be tested first in animal models to
confirm their efficacy in preventing retinopathy. The recent
resolution of the three-dimensional structure of the AM
peptide may help in the rational development of new drugs
that target this system.36
AM, VEGF, and inducible NOS (iNOS) expression are all
stimulated by HIF-1.22,27,37 The IRs are particularly sensitive to
changes in oxygen levels,27,38 causing various degrees of
retinopathy that in some cases can lead to blindness. NO is
postulated as a key factor in the neurotoxicity of ROP,8,27 and
its elevated concentration produces cytotoxic effects on the
retina.7,38,39 Other studies also showed that angiogenesis
stimulated by hypoxia is linked to increased transcription of
HIF-1.40 In normoxia, HIF-1 a is hydroxylated and its
degradation ensues, but in hypoxia, HIF-1 a is not hydroxyl-
ated, allowing its translocation to the nucleus where it
dimerizes with HIF-1 b and acts as a transcription factor for
target genes, which include iNOS,27 VEFG,37 and AM.22
The development of vascularization in the retina is
controlled by interactions between ganglion cells, astrocytes,
and endothelial cells. Ganglion cells secrete platelet-derived
growth factor (PDGF-A) to stimulate astrocyte proliferation,
which in turn promotes secretion of VEGF.41 VEGF signaling
pathway plays a central role modulating the vascularization of
the retina. In our model of PA, we observed that hypoxia
induces a significant increase in VEGF expression in cells of the
ganglion cell layer of the IR, and this increment would be
involved in angiogenesis promotion. Similar results have been
FIGURE 7. Colocalization of AM and GFAP in the IR. Representative
images of AM (red) and GFAP (green) colocalization (yellow) in the
most inner layers of the retina (IR) of PND30 animals. Top: low
expression of both AM and GFAP in animals of the CTL and HYP
groups. Bottom: colocalization and high expression of AM and GFAP in
the IR of PA animals. IR includes the internal limiting membrane, the
retinal nerve fiber layer, and the ganglion cell layer. Nuclei were
counterstained with DAPI (blue). Scale bars: 50 lm.
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published previously,42 where experimental conditions of
severe hypoxia induced an increased expression of VEGF.
Previously, we observed astroglial reaction to PA by both
conventional transmission electron microscopy and light
microscopy with immunohistochemistry for GFAP and tomato
lectin histochemistry.7 In agreement with those previous
studies, GFAP was found in the internal processes of
specialized astrocytes called Mu¨ller cells, which eventually
form the internal limiting membrane.7 In addition, it has been
described that iNOS expression mediated by HIF-1 contributes
to neuronal toxicity,27 which could partly explain the
neurodegeneration previously observed in ganglion cells.7
With regard to GFAP, its expression was observed after 7 days
of PA, localizing in the internal limiting membrane at PA-
PND15, spreading to the perivascular glia of the IR and then to
the inner processes of Mu¨ller cells at the IPL. GFAP increments
were detected in the 7-day-old PA group in relation to CTL,
whereas morphologic changes were detected later (15 days
old), suggesting that molecular changes could precede
morphologic alterations. The results of the present work
suggest that in spite of other processes that may be associated
with retinal thickening, the progressive thickening in the IR
observed starting at postnatal day 15 may be due to a
combination of angiogenesis and gliosis processes.
It has been extensively described that hypothermia is an
effective method for short- and long-term sequelae prevention
in the CNS of rats subjected to PA,3,5,16 including retinal
injury.7,8 A possible mechanism of action to explain the
neuroprotective effect of hypothermia is the inhibition of NO
synthase activity and protein nitration.3,8 The present work
adds AM and VEGF expression inhibition by hypothermia as a
key factor to preserve hypoxic retina from the damage
generated by neovascularization. Experimental therapeutic
strategies against ROP described in the literature include the
use of antioxidants,43 D-penicillamine,44 allopurinol,45 indo-
methacin,46 dexamethasone,47 rofecoxib,48 and others. How-
ever, none of them proved to be as effective as hypothermia in
preventing retinopathy. Recently, a trial employing therapeutic
hypothermia was reported.49 Neonates with hypoxic-ischemic
encephalopathy who participated in the Total Body Hypother-
mia for Neonatal Encephalopathy (TOBY) trial were subjected
to head cooling combined with whole-body cooling to 33.58C
for 72 hours.50 Therapeutic hypothermia was shown to
FIGURE 8. Increased expression of VEGF in the IR induced by PA and reversion by hypothermia. Top: representative images of VEGF
immunolocalization in cells of the ganglion cell layer of the IR in CTL, PA, and HYP animals of 15 and 30 days of age. Increased VEGF expression
(arrows) was observed in PA animals of both ages when compared with the CTLs. HYP did not show significant differences in VEGF expression as it
relates to CTL. IR is the layer conformed by the internal limiting membrane, the retinal nerve fiber layer, and the ganglion cell layer. Scale bars: 10
lm. Bottom: morphometric values of the number of VEGF immunoreactive cells per field, VEGF ICA, and ROD. Significant increments were
observed in all PA groups with respect to CTL at all evaluated parameters. The HYP group did not show significant differences with respect to CTL.
*P < 0.05 significant versus CTL.
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decrease brain tissue injury, and to improve survival and
neurological outcomes at up to 18 months of age.49,51
In conclusion, these results suggest that aberrant angiogen-
esis and exacerbated gliosis are factors implicated in the
increased thickness of the IR as result of hypoxia-ischemia,
whereas treatment with hypothermia is able to prevent those
alterations. The highlight of the present research is that
application of acute hypothermia prevents the development of
retinal injuries, opening the possibility of a new therapeutic
strategy if applied as soon as possible after the hypoxic injury.
Future experiments will be carried out to explore the window
of opportunity for hypothermia intervention to develop a
useful protocol for clinical use.
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